MichaelPishvaianMD

Oncology • Washington, DC

Gastrointestinal Cancer

Physician

Join to view full profile

Dr. Pishvaian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pishvaian's full profile

Already have an account?

Office
5255 Loughboro Road Northwest
Washington, DC 20016
Phone+1 202-660-6500

Fax+1 202-660-6501

Education & Training

MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2004 - 2007
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2001 - 2004
Georgetown University School of MedicineClass of 2001

Certifications & Licensure

DC State Medical License 2004 - 2027
MD State Medical License 2010 - 2025
TX State Medical License 2019 - 2020
VA State Medical License 2001 - 2010
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations Start of enrollment: 2021 Jan 07
Terminated
Phase 2
Roles: Contact, Principal Investigator
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Aug 17
Active, not recruiting
Phase 1, Phase 2
Roles: Principal Investigator
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 Start of enrollment: 2023 Aug 10
Recruiting
Phase 1
Roles: Contact

Publications & Presentations

PubMed

Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma.
Bach Ardalan, Aaron Ciner, Yasmine Baca, Andrew Hinton, Sourat Darabi
Clinical Cancer Research. 2025-01-16
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer.
Patrick M Boland, Heinz-Josef Lenz, Kristen K Ciombor, Vaia Florou, Michael J Pishvaian
Investigational New Drugs. 2024-12-27
1 citations
Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventional irinotecan: A meta-analysis of real-world ev...
Amol Gupta, Ana De Jesus-Acosta, Dung Le, Michael Pishvaian, Neeha Zaidi
Cancer. 2024-11-01